BRISTOL MYERS SQUIBB
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- -
- Established
- 1989-01-01
- Employees
- 30K
- Market Cap
- $97.5B
- Website
- https://www.bms.com/
Observational Real-world Evaluation of Cost of Infections of Rheumatoid Arthritis (RA) Patients on Biologics
Completed
- Conditions
- Rheumatoid Arthritis
- First Posted Date
- 2010-07-21
- Last Posted Date
- 2012-04-13
- Lead Sponsor
- Bristol-Myers Squibb
- Target Recruit Count
- 4000
- Registration Number
- NCT01166620
Japanese Study of Ipilimumab Administered in Combination With Paclitaxel/Carboplatin in Patients With Nonsmall-cell Lung Cancer
Phase 1
Completed
- Conditions
- Non-Small Cell Lung Cancer
- Interventions
- First Posted Date
- 2010-07-19
- Last Posted Date
- 2014-07-22
- Lead Sponsor
- Bristol-Myers Squibb
- Target Recruit Count
- 15
- Registration Number
- NCT01165216
- Locations
- 🇯🇵
Local Institution, Chuo-ku, Tokyo, Japan
A Study of the Safety and Pharmacokinetics of Single Ascending Oral Doses of INX-08189 in Healthy Subjects
- First Posted Date
- 2010-07-09
- Last Posted Date
- 2012-06-22
- Lead Sponsor
- Bristol-Myers Squibb
- Target Recruit Count
- 42
- Registration Number
- NCT01159808
Systematic Review of Antiretroviral Treatments for Chronic Hepatitis B (CHB)
Completed
- Conditions
- Hepatitis B, Chronic
- First Posted Date
- 2010-07-01
- Last Posted Date
- 2010-07-01
- Lead Sponsor
- Bristol-Myers Squibb
- Target Recruit Count
- 100
- Registration Number
- NCT01155427
Experimental Study to Validate the Modified Glucose Disposal Test
Phase 1
Completed
- Conditions
- Diabetes
- Interventions
- Procedure: Insulin, glucose and staple isotopes
- First Posted Date
- 2010-06-29
- Last Posted Date
- 2011-02-23
- Lead Sponsor
- Bristol-Myers Squibb
- Target Recruit Count
- 36
- Registration Number
- NCT01152372
- Locations
- 🇺🇸
Profil Institute For Clinical Research, Inc. (Picr), Chula Vista, California, United States
Japanese Phase 1 Study of BMS-844203 (CT322)
Phase 1
Withdrawn
- Conditions
- Neoplasms
- Interventions
- Drug: BMS-844203 (CT-322)
- First Posted Date
- 2010-06-17
- Last Posted Date
- 2012-02-07
- Lead Sponsor
- Bristol-Myers Squibb
- Registration Number
- NCT01146171
- Locations
- 🇯🇵
Local Institution, Osaka-Sayama-Shi, Osaka, Japan
Efficacy and Safety Study of Abatacept Subcutaneous Plus Methotrexate in Inducing Remission in Adults With Very Early Rheumatoid Arthritis
Phase 3
Completed
- Conditions
- Rheumatoid Arthritis
- Interventions
- First Posted Date
- 2010-06-11
- Last Posted Date
- 2016-01-14
- Lead Sponsor
- Bristol-Myers Squibb
- Target Recruit Count
- 511
- Registration Number
- NCT01142726
- Locations
- 🇺🇸
Johns Hopkins University Division Of Rheumatology, Baltimore, Maryland, United States
🇺🇸Physician Research Collaboration, Llc, Lincoln, Nebraska, United States
🇺🇸Rheumatology Associates Of North Alabama, P.C., Huntsville, Alabama, United States
A Study of BMS-824393 in Combination With Peginterferon Alfa-2a (Pegasys) and Ribavirin (Copegus) in Treatment Naive Subjects With Chronic Hepatitis C Virus Genotype I
Phase 2
Withdrawn
- Conditions
- Chronic Hepatitis C Virus Genotype 1
- Interventions
- First Posted Date
- 2010-06-11
- Last Posted Date
- 2011-03-15
- Lead Sponsor
- Bristol-Myers Squibb
- Registration Number
- NCT01142700
- Locations
- 🇺🇸
Local Institution, Philadelphia, Pennsylvania, United States
🇺🇸Research And Education, Inc., San Diego, California, United States
🇺🇸Gastrointestinal Specialists Of Georgia Pc, Mareitta, Georgia, United States
Dose Escalation With Remicade® and Orencia®
Completed
- Conditions
- Rheumatoid Arthritis
- First Posted Date
- 2010-06-10
- Last Posted Date
- 2012-04-04
- Lead Sponsor
- Bristol-Myers Squibb
- Target Recruit Count
- 5451
- Registration Number
- NCT01141413
Changes in the Use of Opioids, Antidepressants, and Benzodiazepines in Rheumatoid Arthritis Patients Treated With Biologic Agents
Completed
- Conditions
- Rheumatoid Arthritis
- First Posted Date
- 2010-06-07
- Last Posted Date
- 2011-05-17
- Lead Sponsor
- Bristol-Myers Squibb
- Target Recruit Count
- 1810
- Registration Number
- NCT01137838
© Copyright 2025. All Rights Reserved by MedPath